ImmuCell Corp
NASDAQ:ICCC
Gross Margin
ImmuCell Corp
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | US |
Market Cap | 38m USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 288.9B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 168.6B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 113B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 106.9B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 138.6B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 84.5B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 50.6B USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 33.5B USD |
Gross Margin |
75%
|
Country | KR |
Market Cap | 40T KRW |
Gross Margin |
48%
|
Profitability Report
View the profitability report to see the full profitability analysis for ImmuCell Corp.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on ImmuCell Corp's most recent financial statements, the company has Gross Margin of 22.2%.